Essa製藥 EPIX 深 滬
等待開盤 10-03 09:30:00 美东时间
0.2174
+0.012
+5.59%
華盛通- 最 高0.233
- 今 開0.21
- 成交量 426.21万股
- 最 低 0.20
- 昨 收 0.2059
- 總市值 1028.48万
- 52周最高 4.759
- 市盈率 靜 --
- 換手率 9.01%
- 52周最低 -0.291
- 委 比 -71.52%
- 總股本 4730.84万
- 歷史最高 243.309
- 量 比 1.72
- 振 幅 16.03%
- 歷史最低 -0.291
- 每 手 1
- 風險率 1.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ESSA Pharma cuts shareholder payout in revised Xeno deal
ESSA Pharma (NASDAQ:EPIX) fell above 18% premarket on Wednesday after the company revised terms of its merger with biotech firm XenoTherapeutics, lowering expected shareholder payout due to potential ...
09-24 18:35
ESSA Pharma Amends Agreement With XenoTherapeutics, Shareholders To Receive $0.12 Cash And Up To $0.14 Per CVR
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised termsFurther Adjourns Special Meeting to October 3, 2025
09-24 18:07
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised terms Further Adjourns Special Meeting ...
09-24 18:00
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Invivyd (NASDAQ:IVVD) stock increased by 132.3% to $1.3 during Tuesday...
08-26 20:09
ESSA Pharma Confirms $80M Capital Distribution Paid August 22; Shares Began Trading Ex-Dividend August 25 After Correcting Due Bill Period
ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:EPIX) announced on August 14, 2025 that, in connection with the Company's previously announced return of capital distribution in the aggregate amount of US$80,000,000
08-26 04:26
ESSA Pharma Q3 EPS $(0.09) Beats $(0.16) Estimate
ESSA Pharma (NASDAQ:EPIX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.16) by 43.75 percent. This is a 43.75 percent increase over losses of $(0.16) per share from the
08-13 21:12
ESSA Pharma To Distribute $80M To Shareholders
SOUTH SAN FRANCISCO, Calif and VANCOUVER, Canada, Aug. 6, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:EPIX) today announced that, following the Company's receipt of an order from the Supreme
08-07 05:22
ESSA Pharma Announces Tax Implications of Cash Distribution
ESSA Pharma ( ($EPIX) ) has shared an update. On July 31, 2025, ESSA Pharma Inc...
08-01 05:28
ESSA Pharma To Seek Court Approval For Shareholder Payout And Special Meeting Ahead Of Acquisition By XenoTherapeutics
ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:EPIX) today announced that, in connection with its previously announced business combination agreement with XenoTherapeutics, Inc. ("Xeno"), a non-profit
07-24 04:52
Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences
Eupraxia Pharmaceuticals Inc. will present at four upcoming investor conferences in August and September 2025 in Boston and New York. The company, utilizing its DiffuSphere™ technology for targeted drug delivery, focuses on addressing unmet medical needs, particularly in pain and inflammatory diseases. Its lead product, EP-104GI, is in Phase 1b/2 trials for EoE, while EP-104IAR recently met key endpoints in a Phase 2b trial for knee osteoarthriti...
07-22 21:17
